ColgatePalmolive (CL)
(Delayed Data from NYSE)
$96.49 USD
-0.11 (-0.11%)
Updated Jul 25, 2024 04:00 PM ET
Pre-Market: $97.70 +1.21 (1.25%) 8:14 AM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$96.49 USD
-0.11 (-0.11%)
Updated Jul 25, 2024 04:00 PM ET
Pre-Market: $97.70 +1.21 (1.25%) 8:14 AM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Zacks News
Colgate-Palmolive (CL) Up 2.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Clorox (CLX) Stock Still a Great Buy for the Eventual Coronavirus Recovery?
by Benjamin Rains
Clorox topped our quarterly earnings and revenue estimates on May 1, and the stock has jumped 12% since the end of April. Some investors might think the rally is overdone. But is Clorox still a great buy even near its new highs?
Inside the Q1 Earnings Strength of Staples ETFs and Q2 View
by Sanghamitra Saha
Staples stocks had a decent Q1 earnings season but will see negative currency translations in Q2. Plus, not all players in the sector are immune to coronavirus-led lockdowns.
Earnings Data Deluge
by Zacks Equity Research
Earnings Data Deluge.
Colgate (CL) Beats on Q1 Earnings and Sales, Withdraws View
by Zacks Equity Research
Colgate (CL) delivers strong first-quarter 2020 top and bottom lines, driven by strong volume growth and robust pricing, offset by unfavorable foreign currency.
Quarterly Earnings Beats for Exxon, Clorox, AbbVie & More
by Mark Vickery
Where we find our good news this hour is in quarterly earnings season, where these five big-name companies all outperformed expectations.
Colgate-Palmolive (CL) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 2.74% and 1.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Consumer Staples Stock Earnings for May 1: CL, CLX & EL
by Rajani Lohia
Despite the havoc created by the Coronavirus pandemic, consumer staples companies look poised for gains from spiked demand for everyday essentials.
Factors Likely to Decide Colgate's (CL) Fate in Q1 Earnings
by Zacks Equity Research
Colgate-Palmolive's (CL) first-quarter results are likely to reflect investment in brands, favorable pricing strategy and enhancement of e-commerce capabilities.
Will Newell (NWL) Retain its Positive Earnings Trend in Q1?
by Zacks Equity Research
Newell (NWL) gains from transformation efforts that enable it to improve productivity, reduce overhead costs and enhance e-commerce. It expects coronavirus effects to hurt first-quarter 2020 results.
Colgate-Palmolive (CL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Coronavirus Ruins March Retail Sales: Top & Flop ETF Areas
by Sanghamitra Saha
March retail sales saw a record decline due to the coronavirus-led economic shutdown. These ETF areas won/lost in the month.
3 Highly-Ranked Stocks to Buy for the Coronavirus Economy & the Eventual Recovery
by Benjamin Rains
On today's episode of Full Court Finance, we explore three stocks that appear to be buys at the moment and down the road when the economy eventually turns around from the coronavirus downturn...
Why Clorox (CLX) Stock is a Long-Term Buy Far Beyond the Coronavirus
by Benjamin Rains
Clorox sells disinfectant products that kill germs at home and in healthcare settings, which makes it almost tailor-made for the coronavirus economy. Better still, Clorox's portfolio is far more diverse and CLX appears to be a solid longer-term buy...
Soap & Cleaning Materials Stocks Afloat Amid Coronavirus Crisis
by Rajani Lohia
The Soap & Cleaning Materials space stands to gain from the coronavirus-led hike in demand for disinfectants and cleansing agents in the near term.
Coronavirus Hits Feb Retail Sales: Winning & Losing ETFs
by Sanghamitra Saha
If February's grim retail sales report is any guide for March, then investors can easily get an idea about what lies ahead for these specific ETFs.
Colgate's (CL) 2.3% Dividend Hike Boosts Shareholder Value
by Zacks Equity Research
Colgate (CL) hikes quarterly cash dividend to 44 cents per share from 43 cents. Its efforts regarding product innovation and in-store implementation bode well.
Why Is Colgate-Palmolive (CL) Down 2.7% Since Last Earnings Report?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Colgate (CL) Gains From Growth Strategies, Cost Woes Persist
by Zacks Equity Research
Colgate (CL) is benefiting from innovation plans, savings program and expansion strategies. However, increased raw material costs, higher SG&A expenses and currency woes remain concerns.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
Church & Dwight (CHD) Q4 Earnings Meet Estimates, Sales Up
by Zacks Equity Research
Church & Dwight's (CHD) Q4 sales improve on benefits from category growth and market share gains. However, earnings decline year over year.
Colgate (CL) Stock Up on Q4 Sales Beat, Earnings In Line
by Zacks Equity Research
Colgate (CL) beats fourth-quarter 2019 sales estimates on strong volume and pricing gains. The company outlines view for 2020.
Income, Spending & Employment Cost Numbers, Plus More Q4
by Mark Vickery
Personal Income was lighter than expected last month, while Consumer Spending was in-line. Caterpillar, Exxon and Colgate all post Q4 results.
Colgate-Palmolive (CL) Meets Q4 Earnings Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0.00% and 1.85%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Colgate-Palmolive, Kellogg, The Hain Celestial Group and Post Holdings
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Colgate-Palmolive, Kellogg, The Hain Celestial Group and Post Holdings